Three first-of-their-kind cases that redefined how a pharma brand wins attention, trust and sales in Kazakhstan — built and shipped by one team in two quarters (Q4 2025 – Q1 2026).
A young, urban, mobile-first market — a perfect testbed for digital-first pharma marketing.
63% urban · median age 31.6 · 87% smartphone penetration
The largest pharma growth pool — Gen Z and millennials
Overtook TV in 2024 and keeps growing
One idea connects all three cases: go where the audience already is — then bring them home to the brand. Music on TikTok, medicine on delivery apps, honest conversations on YouTube and Telegram.
Kazakhstan's first pharma music jingle — a music-driven awareness campaign for Gen Z, created with musician Ken Dala.
Traditional pharma advertising no longer reaches the 18–35 audience. They actively skip classic medical ads and consume content through music, Reels and TikTok — in a crowded OTC throat-care market.
“We need content our audience wants to watch — not content they skip.”
A strict 5-criteria filter: music-native, Gen Z audience, high engagement, shareable style, Kazakh cultural fit. Only one creator passed all five — Ken Dala (@dashxxmusic): 118K Instagram + 109K TikTok, 73% of followers aged 18–35, engagement 6–9% vs the ~2% KZ benchmark.
An original, catchy, youth-oriented Tanflex jingle — 2 Instagram Reels + 2 TikTok videos, designed to look like native creator content, never like a pharma ad.
Teaser first: audiences engaged with it as music — people did not realise it was advertising and asked for the full song in the comments. Then the full-jingle release across both platforms (March–April 2026).
12+ top Kazakh bloggers and KOLs liked, commented and shared — with zero paid seeding. Users even wrote their own lyric remixes. Branded search queries grew +38% in April vs March.
Kazakh musician · Gen Z native voice. A real producer and performer — the jingle felt like his own track, not a paid ad. Hook-first songs designed for TikTok loops, with high replay value.
Instagram Reels · #159.9Kviews · top performer
Instagram Reels · #248.6Kviews · 9.2% engagement
TikTok · #125Kviews · aligned with a viral audio trend
TikTok · #21,067views · reach-test variant, same audioThe first pharma brand in Kazakhstan to advertise simultaneously across Wolt, Glovo and Yandex.Eda — combined audience of 13M+ users.



| Platform | Budget | Impressions | Clicks | CTR | Units sold |
|---|---|---|---|---|---|
| Wolt Dec 2025 – Jan 2026 | $5,600 | 969,877 | 2,441 | 0.25% | 217 CVR 8.8% |
| Glovo Dec 2025 – Feb 2026 | $10,053 | 186,102 | 1,100 | 0.59% 2.5× Wolt | 456 |
| Yandex.Eda Dec 2025 – Jan 2026 · 5 formats | $11,160 | 9.6M | 461K | 26.18% fullscreen | 825 |
Yandex.Eda CTR combined across 5 ad formats; the fullscreen format alone hit 26.18% — roughly 13× the 0.5–2% industry average.
Delivery platforms cap at ~4–5M users each. Kaspi.kz has 13M+ active users — bigger than Wolt, Glovo and Yandex.Eda combined, with closed-loop purchase data and full ad-to-purchase attribution. The plan: negotiate an ad partnership, launch Tanflex + Muconex with search ads and category promotion, use Kaspi Red instalments for bundles, and benchmark CVR / CPA / ROAS across all four platforms.
ERKEK (Kazakh) = man, masculine strength. The first pharma-supported podcast in Kazakhstan that converts trust into measurable sales — a full content-to-commerce ecosystem for men's health.
Lifta is a sensitive-category brand. ED remains highly stigmatised in Kazakhstan: men aged 30–55 don't discuss it, avoid doctors, and don't trust ads. Traditional advertising simply doesn't work — a trust-first format was needed. Trust first, sale second.



Format: long-form 40–60 min interviews · Kazakh with Russian subtitles · bold questions, no taboo.



15+ provocative cuts from the episodes. 160K+ views, 100% organic — zero ad spend. Top short: 109K views.
3 episodes · 145 minutes of content · 47,500 views · 1,200 YouTube subscribers · $0 spent on promotion.
AI-powered anonymous Q&A on a controlled medical knowledge base, symptom assessment and direct psychologist booking. No registration, no stigma.
The bot issues promo code 50LIFTA (−50% on Wolt). Order → delivered to the door → sale tracked end-to-end. 24% bot-to-sale conversion. Then: real online consultations for long-term loyalty.



Men aged 20–40 across 9 cities of Kazakhstan. For most, it was the first time they sought professional help — ERKEK lowers the barrier.
| KPI | Target | Actual |
|---|---|---|
| Content reach | 100K+ | 207,500 |
| YouTube subscribers | 500+ | 1,200 |
| Telegram community | 300+ | 500+ |
| Bot activations | 50+ | 135 |
| Sales via promo code | 20+ | 32 |
| Wolt sales growth | +50% | +100% |
| Consultations | 10+ | 20 |
| Budget | $6,000 | On budget |
Three first-of-their-kind cases · one team · every KPI exceeded — and every case is now a playbook ready to scale across brands and countries.
Each case was a Kazakhstan pharma first — defensible category positioning that competitors can't easily copy.
Music, delivery apps, podcasts — we went where the audience already lives instead of buying interruption.
Every campaign had attribution from the first touch to a verified sale.
Every case is a documented template, ready to replicate for other AIGP brands and markets.
Three people. Two quarters. Three Kazakhstan pharma firsts.

Project lead · strategy & channel architecture
baglan.uatayev@aigp.kz
Brand owner · cold-season & respiratory portfolio

Brand owner · men's health